Sign up to save your podcasts
Or
Share An Oral Agent for the Treatment of Diabetic Retinopathy
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
An Oral Agent for the Treatment of Diabetic Retinopathy
In our latest update, We discuss the use of APX3330 a novel oral agent for the treatment of diabetic retinopathy with Dr. David Boyer, Retina Vitreous Associates, Adjunct Professor USC Roski Eye Institute.
View all episodes
By Retina Synthesis
4.5
88 ratings
In our latest update, We discuss the use of APX3330 a novel oral agent for the treatment of diabetic retinopathy with Dr. David Boyer, Retina Vitreous Associates, Adjunct Professor USC Roski Eye Institute.
More shows like Retina Synthesis
View all
New Retina Radio by Eyetube
18 Listeners
White Coat Investor Podcast
2,446 Listeners
The Daily
112,758 Listeners
WSJ Minute Briefing
672 Listeners
Up First from NPR
56,463 Listeners
Bogleheads On Investing Podcast
594 Listeners
MedEdTalks - Ophthalmology
4 Listeners
American Journal of Ophthalmology Podcasts Collection
11 Listeners
Experts InSight
51 Listeners
RETINA Journal Podcasts
10 Listeners
Ophthalmology Journal
18 Listeners
Talking Euretina
1 Listeners
RetinaRounds™
0 Listeners
The Last Invention
838 Listeners